Video. LIOUMA TOKITSU, President of Ad Scientiam says: "Cet accompagnement avec Pfizer nous a permis d’imaginer de nouveaux moyens de mettre notre technologie au service des patients dans les maladies rares et l’oncologie"

Let's go back on the 9 months we spent with Pfizer Healthcare Hub, and all the help they gave us through this partnership.

Read the article (in French)

Watch the video (in French)